Blog / semaglutide
Semaglutide Benefits: What the Evidence Says and How to Track Your Progress
A plain guide to semaglutide benefits backed by FDA approvals and research, what they do not promise, and how to track your own progress with your provider.
By Peppy Team6 min read
Semaglutide is one of the most talked about medications of the last few years. Many people first hear about it through weight loss, but its approved uses go further than that. If you or someone you care for is using it under a provider's care, it helps to know what the evidence actually supports, what it does not, and how to keep records that make each appointment more useful.
This guide covers the main semaglutide benefits reported by regulators and research, in plain language. It is not a guide to choosing a medication or a dose. Those decisions belong to you and your healthcare provider.
What semaglutide is
Semaglutide belongs to a class of medicines called GLP-1 receptor agonists. GLP-1 is a hormone your gut releases after you eat. Medicines in this class copy some of its effects.
According to MedlinePlus, the injection helps the pancreas release the right amount of insulin when blood sugar is high. It also slows how fast the stomach empties and may reduce appetite, which can lead to weight loss.
Semaglutide is sold under different brand names for different approved uses. Ozempic and Wegovy are both semaglutide injections, but they are approved for different purposes and follow different labels. Your provider decides which product fits your situation.
The main semaglutide benefits backed by evidence
The list below sticks to uses that regulators have approved or that large studies have reported. Results vary from person to person, and none of them are guaranteed.
1. Blood sugar control in type 2 diabetes
This was the first approved use. MedlinePlus lists blood sugar control in certain patients with type 2 diabetes as a main reason the injection is prescribed. It is usually used alongside diet and exercise, not instead of them.
2. Weight management
In the STEP 1 trial, published in the New England Journal of Medicine, adults with overweight or obesity who used semaglutide along with lifestyle changes lost far more weight on average than those on placebo over 68 weeks. You can read the STEP 1 abstract on PubMed.
Two things are worth keeping in mind. First, those are averages, so some people lost much more and some lost much less. Second, the trial paired the medication with a reduced calorie diet and more physical activity. The medication was one part of a bigger plan.
3. Lower risk of heart attack and stroke in some people
In 2024 the FDA approved Wegovy to reduce the risk of cardiovascular death, heart attack and stroke in adults with heart disease and either obesity or overweight. MedlinePlus also lists a similar use for adults with type 2 diabetes and heart disease. This matters because heart risk is often the bigger health concern behind weight goals.
4. Kidney protection in type 2 diabetes with kidney disease
MedlinePlus lists reducing the risk of worsening kidney disease and death in certain adults with type 2 diabetes and kidney disease as an approved use. This is a specific group of patients, so it does not mean the medication protects the kidneys of everyone who takes it.
5. A treatment option for MASH liver disease
In 2025 the FDA approved Wegovy to treat MASH, a serious form of fatty liver disease, in adults with moderate to advanced liver scarring. The FDA announcement describes MASH as a progressive disease that can lead to cirrhosis and other serious problems. It also notes that Wegovy is approved for obesity or overweight and to reduce cardiovascular events in people at high risk.
What the evidence does not promise
It is easy to read a list like this and expect all of it. A few honest limits:
- Benefits depend on the person. Health history, other medications and many other factors shape what someone experiences.
- Approved uses are specific. Each use applies to a defined group of patients. Being on semaglutide for one reason does not mean the others apply to you.
- Side effects are real. MedlinePlus lists stomach issues such as nausea, vomiting, diarrhea and constipation, along with more serious warnings, including a boxed warning about thyroid tumors seen in rats.
- Stopping can change results. Research has reported that weight often returns after people stop. Any change should be planned with your provider.
Only your provider can judge whether a benefit is likely for you and whether the tradeoffs make sense.
How tracking helps you see your own results
Studies tell you what happened on average. Your records tell you what is happening to you. That is why a simple log is one of the most useful things you can bring to an appointment.
Here is what is worth recording each week.
Doses
Log the date, time and the dose your provider gave you. Note if a dose was late or missed. A clean dose history makes it much easier for your provider to connect changes in how you feel to changes in your plan.
Weight and other measurements
Weigh yourself under similar conditions each time, such as the same morning routine. Some people also track waist size, blood sugar readings or blood pressure if their provider asked them to. Look at the trend over weeks, not single days.
Side effects
Write down what you notice, when it started and how strong it felt, from mild to severe. This helps you describe patterns clearly rather than relying on memory. If something feels serious, contact your provider or seek care right away rather than waiting for the next log entry.
Questions for your next visit
Keep a running list. When you sit down with your provider, you will have specific dates and notes to point to instead of a vague sense of how things went.
Keeping a record in Peppy
Peppy is a GLP-1 tracker app for iPhone that keeps all of this in one place. You can log each dose against the plan your provider set, chart your weight against a goal, and add side effect check-ins next to your doses so patterns are easy to spot. You can read more on the semaglutide tracker page and the GLP-1 tracker page.
A few parts are especially handy for a weekly shot:
- Dose reminders so a busy week does not push a shot off schedule.
- Weight tracking that shows your trend over time.
- A dose history view with logged, missed and on-time doses.
If your provider has you on a vial rather than a pen, the free peptide calculator shows how the dose your provider gave you translates into units on your syringe, based on the vial strength and the water added. The help page on weight, side effects and history explains how those records fit together.
Peppy does not need an account. Your data stays on your iPhone and in your own iCloud backup.
The bottom line
Semaglutide has approved uses in blood sugar control, weight management, heart risk reduction, kidney protection in certain patients and MASH liver disease. Those benefits come from regulators and large trials, and they are averages, not promises. The best way to understand your own experience is to track it honestly and review it with your provider.
Disclaimer
This article is for informational purposes only and is not medical advice. Peppy does not sell peptides or medications and does not recommend any specific peptide or dose. Talk to your healthcare provider before starting, stopping or changing any treatment.
More from the blog

semaglutide6 min read
CagriSema Research Explained: What the REDEFINE Trials Show and What to Track
A plain guide to CagriSema research: what the REDEFINE trials reported, what is still unknown, and what to track in a peptide tracker.
- semaglutide
- glp 1
- tracking

semaglutide6 min read
Semaglutide Tracker: How to Log Doses, Weight and Side Effects Week by Week
A practical semaglutide tracker guide: what to log at every weekly shot, how to track weight and side effects, and what to bring to your provider.
- semaglutide
- glp 1
- dose log

glp 16 min read
What Orforglipron Research Shows About Oral GLP-1 Pills and What to Track
A plain guide to the ATTAIN-1 and ACHIEVE-1 orforglipron trials, how a daily GLP-1 pill differs from injectables, and what to record.
- glp 1
- dose log
- side effects
